Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Interview: CRN Vet Shao Brings Broad Industry Perspective To Herbalife

This article was originally published in The Tan Sheet

Executive Summary

The dietary supplement industry lost one of its most active and vocal scientific leaders in Washington when Andrew Shao departed the Council for Responsible Nutrition for an executive post with Herbalife.

You may also be interested in...



Herbalife Investments Streamline Supply Chain, Attract Industry Talent

Herbalife’s “seed-to-feed” vertical integration strategy includes a $130 million facility in North Carolina to open in 2014 and the continued recruitment of dietary supplement scientific and regulatory experts. The multilevel marketer also is deploying novel modes of product distribution across its markets.

Herbalife Investments Streamline Supply Chain, Attract Industry Talent

Herbalife’s “seed-to-feed” vertical integration strategy includes a $130 million facility in North Carolina to open in 2014 and the continued recruitment of dietary supplement scientific and regulatory experts. The multilevel marketer also is deploying novel modes of product distribution across its markets.

Supplier Qualification Guideline Touts Flexibility, Defers Best Practices

The Standardized Information on Dietary Ingredients Work Group publishes a guide to help supplement firms qualify ingredient suppliers under FDA good manufacturing practices. But with only three out of five major industry associations involved, not everyone is on board with the SIDI efforts.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS104991

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel